XML 17 R2.htm IDEA: XBRL DOCUMENT v3.24.1.u1Close
Condensed Consolidated Balance Sheets - USD ($)
$ in Millions
Mar. 31, 2024
Dec. 31, 2023
Assets    
Cash and cash equivalents $ 3,608 $ 3,686
Receivables 77 71
Inventories:    
Leaf tobacco 610 649
Other raw materials 199 204
Work in process 27 22
Finished product 405 340
Inventory, net 1,241 1,215
Income taxes 173 496
Other current assets 99 117
Total current assets 5,198 5,585
Property, plant and equipment, at cost 4,515 4,582
Less accumulated depreciation 2,891 2,930
Property, plant and equipment, net 1,624 1,652
Goodwill 6,945 6,791
Other intangible assets, net 13,439 13,686
Investments in equity securities 8,396 10,011
Other assets 873 845
Total Assets 36,475 38,570 CloseClose
Liabilities    
Current portion of long-term debt 0 1,121
Accounts payable 504 582
Accrued liabilities:    
Marketing 720 716
Settlement charges 3,420 2,563
Other 1,901 1,902
Deferred gain from the sale of IQOS System commercialization rights 2,700 2,700
Dividends payable 1,690 1,735
Total current liabilities 10,935 11,319
Long-term debt 25,042 25,112
Deferred income taxes 2,699 2,799
Accrued pension costs 128 130
Accrued postretirement health care costs 1,079 1,079
Other liabilities 1,656 1,621
Total liabilities 41,539 42,060 CloseClose
Contingencies (Note 13)
Stockholders’ Equity (Deficit)    
Common stock, par value $0.33 1/3 per share (2,805,961,317 shares issued) 935 935
Additional paid-in capital 5,521 5,906
Earnings reinvested in the business 31,535 31,094
Accumulated other comprehensive losses (2,266) (2,673)
Cost of repurchased stock (1,088,334,893 shares at March 31, 2024 and 1,042,499,542 shares at December 31, 2023) (40,839) (38,802)
Total stockholders’ equity (deficit) attributable to Altria (5,114) (3,540) CloseClose
Noncontrolling interests 50 50
Total stockholders’ equity (deficit) (5,064) (3,490)
Total Liabilities and Stockholders’ Equity (Deficit) $ 36,475 $ 38,570